Kenvue reported a 3.3% increase in net sales to $3.9 billion and a 3.6% increase in organic growth for the third quarter of 2023. The company's performance was driven by strength in the Self Care segment, while facing challenges from portfolio rationalization and market softness in China. The company has tightened its full year outlook due to foreign exchange headwinds and a slow start to the cough, cold, and flu season.
Net sales increased by 3.3% to $3.9 billion, with organic growth of 3.6%.
Reported diluted EPS was $0.23, and adjusted diluted EPS was $0.31.
Gross profit margin was 57.5%, and adjusted gross profit margin was 59.4%.
The Board of Directors declared a $0.20 cash dividend per share payable in the fourth quarter and authorized a share repurchase program.
Kenvue tightened its net sales outlook expecting fiscal 2023 reported Net sales growth to be in the range of 4.0% to 4.5% and Organic growth to be in the range of 5.5% to 6.0%.Kenvue expects fiscal 2023 Adjusted diluted earnings per share to be in the range of $1.26 to $1.28.
Visualization of income flow from segment revenue to net income